Be the first to know about every new Coronavirus story
Turkey’s shock central bank swap, Covid-era drug shortages, Goldman Sachs enforced weekend rule
Investor confidence in Turkey is shaken by the shock dismissal of the head of the central bank and the appointment of a new central banker with unorthodox ideas on how to tackle the country’s economic challenges, the increased production of the Covid-19 vaccine is creating shortages of other medicines, and Goldman Sachs bows to workplace complaints by junior bankers.
Turkey’s lira tumbles after Erdogan sacks central bank chief
https://www.ft.com/content/6be3efd1-a8e9-47a8-abac-966db2d3cf93
Push to make Covid vaccines causes US drug shortages
https://www.ft.com/content/b3ac261e-2675-4679-9356-53aa6d812ad7
David Solomon commits to Saturdays off for Goldman Sachs bankers
https://www.ft.com/content/58ca979f-3110-4613-8f85-81d8704cd4ad
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published
